St. Thomas' hospital cardioplegia: Enhanced protection with exogenous creatine phosphate

Annals of Thoracic Surgery

Volumn 61, Issue 1, 1996, Pages 67-75

  Chambers, David J ^a,b   Haire, Kevin ^a   Morley, Nicola ^a   Fairbanks, Lynne ^a   Strumia, Ettore ^a   Young, Christopher P ^a   Venn, Graham E ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE PHOSPHATE; ST THOMAS HOSPITAL SOLUTION;

ADULT; AGED; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGIONAL PERFUSION;

EID: 0030064163     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(95)00819-5     Document Type: Article

References (30)

1. Hearse DJ, Stewart DA, Braimbridge MV. Cellular protection during myocardial ischemia. The development and characterization of a procedure for the induction of reversible ischemic arrest. Circulation 1976;54:193-202.
2. Braimbridge MV, Chayen J, Bitensky L, et al. Cold cardioplegia or continuous coronary perfusion? J Thorac Cardiovasc Surg 1977;74:900-6.
3. Ledingham SJM, Braimbridge MV, Hearse DJ. The St. Thomas' Hospital cardioplegic solution. A comparison of the efficacy of two formulations. J Thorac Cardiovasc Surg 1987; 93:240-6.
4. Chaudry IH, Baue AE. The use of substrates and energy in the treatment of shock. Adv Shock Res 1980;3:27-46.
5. Robinson LA, Braimbridge MV, Hearse DJ. Creatine phosphate: an additive myocardial protective and antiarrhythmic agent in cardioplegia. J Thorac Cardiovasc Surg 1984;87: 190-200.
6. Robinson LA, Braimbridge MV, Hearse DJ. Enhanced myocardial protection with high-energy phosphates in St. Thomas' Hospital cardioplegic solution. Synergism of adenosine triphosphate and creatine phosphate. J Thorac Cardiovasc Surg 1987;93:415-27.
7. Chambers DJ, Braimbridge MV, Kosker S, et al. Creatine phosphate (Neoton) as an additive to St. Thomas' Hospital cardioplegic solution (Plegisol). Results of a clinical study. Eur J Cardio-thorac Surg 1991;5:74-81.
8. Chayen J, Bitensky L. Practical histochemistry. Chichester: Wiley, 1991:1-8.
9. Braimbridge MV, Hearse DJ, Chayen J, Bitensky L, Cankovic-Darracott S. Cold cardioplegia versus continuous coronary perfusion: clinical and cytochemical assessment. In: Longmore DB, ed. Modern cardiac surgery. London: MTP Press, 1978:285-98.
10. Braimbridge MV, Cankovic-Darracott S. Quantitative polarization microscopy and cytochemistry in assessing myocardial function. In: Pattison JR, Bitensky L, Chayen J, eds. Quantitative cytochemistry and its applications. London: Academic Press, 1979:221-30.
11. Cankovic-Darracott S, Braimbridge MV, Williams BT, Bitensky L, Chayen J. Myocardial preservation during aortic valve surgery. Assessment of five techniques by cellular chemical and biophysical methods. J Thorac Cardiovasc Surg 1977;73: 699-706.
12. Cankovic-Darracott S. Methods for assessing preservation techniques - invasive methods (enzymatic, cytochemical). In: Engelman RM, Levitsky S, eds. A textbook of clinical cardioplegia. New York: Futura, 1982:43-60.
13. Chayen J, Bitensky L, Braimbridge MV, Darracott-Cankovic S. Increased myosin orientation during muscle contraction: a measure of cardiac contractility. Cell Biochem Funct 1985;3: 101-14.
14. Schaper J, Scheld HH, Schmidt U, Herlein F. Ultrastructural study comparing the efficacy of five different methods of intraoperative myocardial protection in the human heart. J Thorac Cardiovasc Surg 1986;92:47-55.
15. Smolenski RT, Lachno DR, Ledingham SJM, Yacoub MH. Determination of sixteen nucleotides, nucleosides and bases using high-performance liquid chromatography and its application to the study of purine metabolism in hearts for transplantation. J Chromatogr 1990;527:414-20.
16. Seymour A-ML. Evaluation of myocardial energy status in vivo by NMR spectroscopy. Basic Res Cardiol 1993;88:385-95.
17. Hearse DJ, Tanaka K, Crome R, Manning AS. Creatine phosphate and protection against reperfusion-induced arrhythmias in the rat heart Eur J Pharmacol 1986;131:21-30.
18. Semenovsky ML, Shumakov VI, Sharov VG, et al. Protection of ischemic myocardium by exogenous phosphocreatine. II. Clinical, ultrastructural, and biochemical evaluation. J Tho rac Cardiovasc Surg 1987;94:762-9.
19. Zucchi R, Poddighe R, Limbruno U, et al. Protection of isolated rat heart from oxidative stress by exogenous creatine phosphate. J Mol Cell Cardiol 1989;21:67-73.
20. Conorev EA, Sharov VG, Saks VA. Improvement in contractile recovery of isolated rat heart after cardioplegic ischaemic arrest with endogenous phosphocreatine: involvement of antiperoxidative effect? Cardiovasc Res 1991;25:164-71.
21. Bernier M, Hearse DJ, Manning AS. Reperfusion-induced arrhythmias and oxygen-derived free radicals. Studies with "anti-free radical" interventions and a free radical-generating system in the isolated perfused rat heart. Circ Res 1986;58: 331-40.
22. Bernier M, Kusama Y, Borgers M, et al. Pharmacological studies of arrhythmias induced by rose bengal photoactivation. Free Radic Biol Med 1991;10:287-96.
23. Penny WJ, Sheridan DJ. Arrhythmias and cellular electrophysiological changes during myocardial "ischaemia" and reperfusion. Cardiovasc Res 1983;17:363-72.
24. Hoffman PC, Okita GT. Penetration of ATP into the myocardium. Proc Soc Exp Biol Med 1965;119:573-6.
25. Chaudry IH, Gould MK. Evidence for the uptake of ATP by rat soleus muscle in vitro. Biochim Biophys Acta 1970;196: 320-6.
26. Sharov VG, Saks VA, Kupriyanov VV, et al. Protection of ischemic myocardium by exogenous phosphocreatine. I. Morphologic and phosphorous 31-nuclear magnetic resonance studies. J Thorac Cardiovasc Surg 1987;94:749-61.
27. Ganz W, Swan HJC. A new technique for measurement of cardiac output by thermodilution in man. Am J Cardiol 1971;27:392-6.
28. Breisblatt WM, Stein KL, Wolfe CJ, et al. Acute myocardial dysfunction and recovery: a common occurrence after coronary bypass surgery. J Am Coll Cardiol 1990;15:1261-9.
29. Bolli R. Myocardial stunning in man. Circulation 1992;86: 1671-91.
30. Robinson LA, Harwood DL. Exogenous creatine phosphate: favorable calcium-altering effects in St. Thomas' Hospital cardioplegic solution. J Am Coll Cardiol 1988;11:170A.